Updated Jul 16, 2026
Swain Judith L has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Judith L. Swain is a director at Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing treatments for human diseases. She has participated in SEC filings related to her role but is not widely recognized in public domains.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | LXRX | LEXICON PHARMACEUTICALS, INC. | M — Option exercise | 89.3K | $0.00 | |
| 2025-05-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | M — Option exercise | 36.8K | $0.00 |
Judith L. Swain is a director at Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing treatments for human diseases. She has participated in SEC filings related to her role but is not widely recognized in public domains.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Swain Judith L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.